Cibus, Inc. (CBUS)
NCM · Healthcare · Biotechnology
$1.23
-1.60%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$93.9M
Shares Outstanding
76.3M
P/S (TTM)
21.9x
Exchange
NCM
Currency
USD
About Cibus, Inc.
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 933K | 615K | 1.1M | 1.7M |
| Operating Income | -17.9M | -15.4M | -13.5M | -12.1M |
| Net Income | -25.4M | -23.5M | -31.3M | -21.2M |
| Diluted EPS | $-0.61 | $-0.44 | $-0.59 | $-0.33 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 157K | 1.8M | 4.3M | 3.6M |
| Gross Profit | 157K | 1.8M | 4.3M | 3.6M |
| Operating Income | -22.4M | -69.5M | -77.0M | -67.5M |
| Net Income | -16.9M | -267.6M | -251.4M | -127.1M |
| Diluted EPS | $-18.36 | $-25.95 | $-10.83 | $nan |